WO2002020556A3 - Haplotypes du gene gpr68 - Google Patents

Haplotypes du gene gpr68 Download PDF

Info

Publication number
WO2002020556A3
WO2002020556A3 PCT/US2001/028023 US0128023W WO0220556A3 WO 2002020556 A3 WO2002020556 A3 WO 2002020556A3 US 0128023 W US0128023 W US 0128023W WO 0220556 A3 WO0220556 A3 WO 0220556A3
Authority
WO
WIPO (PCT)
Prior art keywords
gpr68
gene
haplotypes
disclosed
haplotyping
Prior art date
Application number
PCT/US2001/028023
Other languages
English (en)
Other versions
WO2002020556A2 (fr
Inventor
Alison E Anastasio
Jin-Hua Han
Stefanie E Kliem
Original Assignee
Genaissance Pharmaceuticals
Alison E Anastasio
Jin-Hua Han
Stefanie E Kliem
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals, Alison E Anastasio, Jin-Hua Han, Stefanie E Kliem filed Critical Genaissance Pharmaceuticals
Priority to AU2001288868A priority Critical patent/AU2001288868A1/en
Publication of WO2002020556A2 publication Critical patent/WO2002020556A2/fr
Publication of WO2002020556A3 publication Critical patent/WO2002020556A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/172Haplotypes
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medical Informatics (AREA)
  • Evolutionary Biology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

L'invention concerne de nouveaux variants génétiques du gène du récepteur 68 couplé aux protéines G (GPR68). L'invention concerne également divers génotypes, haplotypes et diverses paires de haplotypes existants dans la population globale des Etats-Unis pour le gène GPR68. L'invention concerne aussi des compositions et des méthodes de haplotypage et/ou génotypage du gène GPR68 chez un individu. L'invention concerne également des polynucléotides définis par les haplotypes ici décrits.
PCT/US2001/028023 2000-09-07 2001-09-07 Haplotypes du gene gpr68 WO2002020556A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001288868A AU2001288868A1 (en) 2000-09-07 2001-09-07 Haplotypes of the gpr68 gene

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23085700P 2000-09-07 2000-09-07
US60/230,857 2000-09-07

Publications (2)

Publication Number Publication Date
WO2002020556A2 WO2002020556A2 (fr) 2002-03-14
WO2002020556A3 true WO2002020556A3 (fr) 2004-11-25

Family

ID=22866847

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/028023 WO2002020556A2 (fr) 2000-09-07 2001-09-07 Haplotypes du gene gpr68

Country Status (2)

Country Link
AU (1) AU2001288868A1 (fr)
WO (1) WO2002020556A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003266238A1 (en) * 2002-08-05 2004-02-25 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with ovarian cancer g-protein coupled receptor 1 (ogr-1)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
XU Y. ET AL: "Identification of human OGR1, a novel G protein-coupled receptor that maps to chromosome 14", GENOMICS, vol. 35, 1996, pages 397 - 402, XP002928274 *

Also Published As

Publication number Publication date
WO2002020556A2 (fr) 2002-03-14
AU2001288868A1 (en) 2002-03-22

Similar Documents

Publication Publication Date Title
WO2002006294A3 (fr) Haplotypes du gene mmp13
WO2002026764A3 (fr) Haplotypes du gene ccr6
WO2002008425A3 (fr) Haplotypes du gene adrb3
WO2002020556A3 (fr) Haplotypes du gene gpr68
WO2002006446A3 (fr) Haplotypes du gene edg6
WO2001087904A3 (fr) Haplotypes du gene gpr4
WO2001090128A3 (fr) Haplotypes du gene gpr3
WO2002050098A3 (fr) Haplotypes du gene du recepteur de la prolactine (prlr)
WO2002016399A3 (fr) Haplotypes du gene tacr1
WO2002032928A3 (fr) Haplotypes du gene hrh1
WO2002038587A3 (fr) Haplotypes du gene grm8
WO2002032924A3 (fr) Haplotypes du gene chrm5
WO2001090118A3 (fr) Haplotypes du gene edn2
WO2001090124A3 (fr) Haplotypes du gene gpr31
WO2002026766A3 (fr) Haplotypes du gene sstr4
WO2001096350A3 (fr) Haplotypes du gene grm3
WO2002012562A3 (fr) Haplotypes du gene pla2g1b
WO2002036609A3 (fr) Haplotypes du gene chrm4
WO2002012561A3 (fr) Haplotypes du gene or1g1
WO2002030949A3 (fr) Haplotypes du gene ltb4r
WO2002090378A3 (fr) Haplotypes du gene de ces2
WO2001087908A3 (fr) Haplotypes du gene ccr3
WO2002012499A3 (fr) Haplotypes du gene ntf3
WO2002026770A3 (fr) Haplotypes du gene admr
WO2002002580A3 (fr) Haplotypes du gene etfb

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP